Is it growing?
Is INSM growing?
Insmed Incorporated has grown revenue 62% a year over three years and 46% a year over five.
+62%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +46%
Revenue growth, 5-year rate · +62% over three · growth has picked up over the last three years
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $188M
- Revenue FY2022
- $245M
- Revenue FY2023
- $305M
- Revenue FY2024
- $364M
- Revenue FY2025
- $606M
Annual income statements as filed with the SEC.
Biotechnology
Ranks #140 of 145 by Smart Score